Related Experiment Video
Updated: Oct 30, 2025

08:46
Fertility Preservation Through Oocyte Vitrification: Clinical and Laboratory Perspectives
Published on: September 16, 2021
6.2K
Employer-Sponsored Egg Freezing: Carrot or Stick?
Molly Johnston1,2, Giuliana Fuscaldo3,4, Nadine Maree Richings1
1Department of Obstetrics and Gynaecology, Monash University, Clayton, Australia.
AJOB Empirical Bioethics
|July 5, 2021
Summary
Employer-sponsored egg freezing (ESEF) is viewed with mixed opinions by Australian women. While some see it as promoting reproductive autonomy, others worry about potential pressure to delay childbearing.
Area of Science:
- Reproductive Health
- Sociology of Work
- Bioethics
Background:
- Employer-sponsored egg freezing (ESEF) is increasingly offered by companies globally.
- Academic debate exists on whether ESEF enhances reproductive autonomy or reinforces the "career vs. family" dilemma.
- Public perception of ESEF remains largely unexplored.
Purpose of the Study:
- To investigate women's attitudes towards employer-sponsored egg freezing in Australia.
- To explore potential demographic associations with views on ESEF.
Main Methods:
- Online cross-sectional survey of 656 women aged 18-60 in Victoria, Australia.
- Analysis of views on ESEF appropriateness using multinominal logistic regression.
- Thematic analysis of free-text comments.
Main Results:
- Women's opinions on ESEF were divided: 42% appropriate, 27% inappropriate, 31% unsure.
- Older women and part-time employees showed significantly less support for ESEF.
- Concerns included pressure to delay childbearing and exacerbate ART access inequities, while some saw potential for increased options.
Conclusions:
- ESEF is not universally opposed, but acceptance may depend on specific conditions.
- Conditions for acceptance include reproductive freedom protections and balanced support for career and family.
- Potential role for state intervention to ensure equitable implementation and conditions for ESEF.
Related Concept Videos
Meiosis II
188.1K
Meiosis II is the second and final stage of meiosis. It relies on the haploid cells produced during meiosis I, each of which contain only 23 chromosomes—one from each homologous initial pair. Importantly, each chromosome in these cells is composed of two joined copies, and when these cells enter meiosis II, the goal is to separate such sister chromatids using the same microtubule-based network employed in other division processes. The result of meiosis II is two haploid cells, each...
188.1K
Infertility in Females
2.8K
Female infertility is defined as the inability to conceive after a year of regular, unprotected intercourse and affects about 10–15% of couples worldwide. The primary cause of female infertility is ovulatory disorders, which hinder the release of eggs. These disorders can be classified as hypothalamic amenorrhea, polycystic ovarian syndrome (PCOS), premature ovarian failure, and hyperprolactinemic anovulation disorders.
Endometriosis, a condition characterized by abnormal growth of...
Endometriosis, a condition characterized by abnormal growth of...
2.8K
In Vitro Fertilization
578
In vitro fertilization (IVF) is a form of assisted reproductive technology where an egg is fertilized with sperm in a controlled laboratory environment before transferring the resulting embryo into the uterus. This process is designed to help individuals and couples experiencing difficulties conceiving.
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
The IVF process begins with ovarian stimulation, during which reproductive endocrinologists prescribe hormonal medications to stimulate the ovaries to produce multiple eggs instead of the single...
578
Infertility in Males
371
Male infertility affects millions of couples worldwide, arising from various factors that impact different stages of the reproductive process. An endocrine imbalance resulting from conditions like hypogonadism, Klinefelter syndrome, or pituitary disorders can disrupt hormone levels and reduce sperm production. Testicular defects, such as tumors, cryptorchidism, atrophic testes, abnormal sperm morphology, and low sperm count or motility, may arise due to genetic factors, structural...
371

